Andrew Wang, MD

Professor of Medicine
Vice Chief for Clinical Services
Campus mail 7401 Hosp North, 2301 Erwin Road, Durham, NC 27710
Phone (919) 681-6197

Structural heart diseases, including valvular heart disease, hemodynamics, infective endocarditis, and hypertrophic cardiomyopathy

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1995 - 1997
  • Assistant Chief of Service, Medicine, Johns Hopkins University, 1994 - 1995
  • Fellow in Cardiology, Medicine, Duke University, 1993 - 1994
  • Medical Resident, Medicine, Johns Hopkins University, 1990 - 1993
  • M.D., Duke University, 1990

Publications

Vavalle, John P., Harry Phillips, Sara Holleran, Andrew Wang, Christoper M. O’Connor, Peter K. Smith, G Chad Hughes, J Kevin Harrison, and Manesh R. Patel. “Access to Care: Geographical Variations in the Diagnosis and Treatment of Aortic Stenosis in North Carolina.” In Circulation, Vol. 126. LIPPINCOTT WILLIAMS & WILKINS, 2012.

Scholars@Duke

Nelson, James A., John Vavalle, Sharif Halim, G. C. Hughes, Andrew Wang, Lynne Koweek, Donald Glower, Jeff Gaca, John Alexander, and John K. Harrison. “Who is Being Referred for TAVR?: Patterns of Referral for TAVR at a Single Academic Medical Center.” Circulation 126, no. 21 (November 20, 2012).

Scholars@Duke

Athan, E., and A. Wang. “Cardiac device infective endocarditis and patient survival - Reply.” Jama  Journal of the American Medical Association 308, no. 8 (August 22, 2012).

Scholars@Duke

Wang, Andrew. “The changing epidemiology of infective endocarditis: the paradox of prophylaxis in the current and future eras..” Journal of the American College of Cardiology 59, no. 22 (May 2012): 1977–78. https://doi.org/10.1016/j.jacc.2012.02.030.

PMID
22624838
Full Text

Athan, Eugene, Vivian H. Chu, Pierre Tattevin, Christine Selton-Suty, Phillip Jones, Christoph Naber, José M. Miró, et al. “Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices..” Jama 307, no. 16 (April 25, 2012): 1727–35. https://doi.org/10.1001/jama.2012.497.

PMID
22535857
Full Text

Herrmann, Howard C., Zachary M. Gertz, Frank E. Silvestry, Susan E. Wiegers, Y Joseph Woo, James Hermiller, Douglas Segar, et al. “Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial..” Journal of the American College of Cardiology 59, no. 14 (April 2012): 1312–19. https://doi.org/10.1016/j.jacc.2011.12.023.

PMID
22464260
Full Text

Glower, Donald, Gorav Ailawadi, Michael Argenziano, Michael Mack, Alfredo Trento, Andrew Wang, D Scott Lim, et al. “EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure..” The Journal of Thoracic and Cardiovascular Surgery 143, no. 4 Suppl (April 2012): S60–63. https://doi.org/10.1016/j.jtcvs.2012.01.047.

PMID
22423604
Full Text

Kiefer, Todd L., Andrew Wang, G Chad Hughes, and Thomas M. Bashore. “Management of patients with bicuspid aortic valve disease..” Current Treatment Options in Cardiovascular Medicine 13, no. 6 (December 2011): 489–505. https://doi.org/10.1007/s11936-011-0152-7.

PMID
22009692
Full Text

Kiefer, Todd, Lawrence Park, Christophe Tribouilloy, Claudia Cortes, Roberta Casillo, Vivian Chu, Francois Delahaye, et al. “Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure..” Jama 306, no. 20 (November 23, 2011): 2239–47. https://doi.org/10.1001/jama.2011.1701.

PMID
22110106
Full Text

Pages